Welk et al. (2015) elaborated on the effect of treatment initiation with tamsulosin, alfuzosin or silodosin on the risk for fractures and falls [51], and Siemens et al. (2021) investigated the association of alpha-1 antagonist treatment and cardiac failure [55]. This evidence concerns the gene PSMA6 and heart failure.